Literature DB >> 9047244

Morphologic pattern of tenascin as a diagnostic biomarker in colon cancer.

B F Iskaros1, K E Tanaka, X Hu, A S Kadish, J J Steinberg.   

Abstract

BACKGROUND: Immunohistochemical methods were used to study the pattern of expression of tenascin (TN) in invasive colon cancer and its relation to prognosis.
METHODS: Sixty patients (29 males, 31 females) with a mean age of 77 years were studied. TN expression was evaluated by immunohistochemistry using paraffin-embedded tissue sections, TN expression levels were correlated with patient age, tumor stage, and survival.
RESULTS: TN positivity varied from trace to 4+. Staining patterns were as follows: in well-differentiated cancer, TN fibers form thick bands around invading tumor glands. In poorly differentiated cancer, TN fibers had an interstitial pattern surrounding individual tumor cells. Using Cox's proportional hazard regression method, survival was significantly related to TN score (P < 0.0001) and stage of disease (P < 0.05). No significant relationship was found between survival and age (P = 0.375).
CONCLUSION: Patients with more TN expression had better long-term survival than patients with no or weak TN expression. Pathologic and clinical entities in colon cancer have distinct immunohistochemical TN matrix patterns that may correlate with predictive value and long-term survival.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9047244     DOI: 10.1002/(sici)1096-9098(199702)64:2<98::aid-jso2>3.0.co;2-j

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  3 in total

Review 1.  Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization.

Authors:  Andrew J Sawyer; Themis R Kyriakides
Journal:  Adv Drug Deliv Rev       Date:  2016-01-04       Impact factor: 15.470

2.  Clinical significance of large tenascin-C spliced variant as a potential biomarker for colorectal cancer.

Authors:  Akihiko Takeda; Yoshihide Otani; Hiroyoshi Iseki; Hideki Takeuchi; Kimiyasu Aikawa; Satoru Tabuchi; Nozomi Shinozuka; Toshiaki Saeki; Yasushi Okazaki; Isamu Koyama
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

3.  Tenascin-C serum levels and its prognostic power in non-small cell lung cancer.

Authors:  Florian Gebauer; Suyin Gelis; Hilke Zander; Karl-Frederick Meyer; Gerrit Wolters-Eisfeld; Jakob R Izbicki; Maximilian Bockhorn; Michael Tachezy
Journal:  Oncotarget       Date:  2016-04-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.